MNDL Bio

MNDL BioMNDL Bio
MNDL Bio

MNDL Bio

Synthetic biology startup optimizing gene expression for food and biotech applications.

2023Active10San Francisco, United States
Rate

About

MNDL Bio is a synthetic biology company focused on reducing the cost and production time for food and biotechnology applications. They achieve this through advanced computational platforms designed to optimize gene expression, enabling more efficient and scalable biological manufacturing.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does MNDL Bio do?

MNDL Bio is a synthetic biology company focused on reducing the cost and production time for food and biotechnology applications. They achieve this through advanced computational platforms designed to optimize gene expression, enabling more efficient and scalable biological manufacturing.

How much funding has MNDL Bio raised?

MNDL Bio has raised a total of $2M in funding. The most recent round on record is Pre-Seed.

Where is MNDL Bio headquartered?

MNDL Bio is headquartered in San Francisco, United States.

When was MNDL Bio founded?

MNDL Bio was founded in 2023.

What industry does MNDL Bio operate in?

MNDL Bio operates in Life Sciences, Synthetic Biology, Genetics, Food, Biotech, Genomics.

How many employees does MNDL Bio have?

MNDL Bio has approximately 10 people on record.

What is MNDL Bio's revenue?

StartupHub estimates MNDL Bio's annual revenue at $1.7M (range $953K to $2.7M, 64% confidence), based on comparable companies in the sector.

What is MNDL Bio's valuation?

StartupHub estimates MNDL Bio's effective valuation at $7.9M (range $5.0M to $12.0M, 15% confidence), based on comparable companies in the sector.